MX2019014445A - Preparacion hidratante topica. - Google Patents
Preparacion hidratante topica.Info
- Publication number
- MX2019014445A MX2019014445A MX2019014445A MX2019014445A MX2019014445A MX 2019014445 A MX2019014445 A MX 2019014445A MX 2019014445 A MX2019014445 A MX 2019014445A MX 2019014445 A MX2019014445 A MX 2019014445A MX 2019014445 A MX2019014445 A MX 2019014445A
- Authority
- MX
- Mexico
- Prior art keywords
- topical preparation
- moisturizing topical
- moisturizing
- animal
- pharmaceutically acceptable
- Prior art date
Links
- 230000003020 moisturizing effect Effects 0.000 title abstract 5
- 230000000699 topical effect Effects 0.000 title abstract 5
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229940043138 pentosan polysulfate Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
La presente invención proporciona una preparación hidratante tópica novedosa que contiene como un ingrediente activo al menos uno seleccionada del polisulfato de pentosán; sales farmacéuticamente aceptables de polisulfato de pentosán; y solvatos farmacéuticamente aceptables del mismo. La preparación hidratante tópica de la presente invención, que contiene una sustancia libre 5 de componentes derivados de animales como un ingrediente activo, se puede producir como una preparación hidratante tópica libre de componentes derivados de animales, según sea necesario.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017108001 | 2017-05-31 | ||
JP2017175133 | 2017-09-12 | ||
JP2017244051 | 2017-12-20 | ||
PCT/JP2018/020644 WO2018221547A1 (ja) | 2017-05-31 | 2018-05-30 | 保湿外用剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019014445A true MX2019014445A (es) | 2020-02-10 |
Family
ID=64455406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019014445A MX2019014445A (es) | 2017-05-31 | 2018-05-30 | Preparacion hidratante topica. |
Country Status (12)
Country | Link |
---|---|
US (1) | US11278485B2 (es) |
EP (1) | EP3632451A4 (es) |
JP (1) | JP6555431B2 (es) |
KR (2) | KR20200011467A (es) |
CN (1) | CN110678189A (es) |
AU (1) | AU2018276567B2 (es) |
BR (1) | BR112019025030A2 (es) |
CA (1) | CA3065747A1 (es) |
MX (1) | MX2019014445A (es) |
PH (1) | PH12019502676A1 (es) |
SG (2) | SG10201913607WA (es) |
WO (1) | WO2018221547A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112020004787A2 (pt) * | 2017-09-12 | 2020-09-24 | Oji Holdings Corporation | polissulfato de pentosano, composição farmacêutica, anticoagulante, e, método para produzir polissulfato de pentosano |
CN111511773B (zh) | 2017-12-20 | 2023-01-13 | 王子控股株式会社 | 戊聚糖多硫酸酯以及含有戊聚糖多硫酸酯的药物 |
WO2019151285A1 (ja) * | 2018-01-31 | 2019-08-08 | マルホ株式会社 | 皮膚外用組成物 |
WO2019151287A1 (ja) * | 2018-01-31 | 2019-08-08 | マルホ株式会社 | 皮膚外用組成物 |
WO2019151286A1 (ja) * | 2018-01-31 | 2019-08-08 | マルホ株式会社 | 皮膚外用組成物 |
WO2022114111A1 (ja) * | 2020-11-27 | 2022-06-02 | マルホ株式会社 | 医薬品又は化粧品用組成物 |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4843100B1 (es) | 1969-09-05 | 1973-12-17 | ||
US4168742A (en) | 1978-03-27 | 1979-09-25 | Hudson Products Corporation | Tube bundle |
FR2538404B1 (es) | 1982-12-28 | 1985-08-23 | Anic Spa | |
FR2543145B1 (fr) | 1983-03-24 | 1986-10-17 | Sanofi Sa | Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante |
JPS60112708A (ja) | 1983-11-24 | 1985-06-19 | Maruho Kk | 皮膚用保湿剤 |
FR2572731B1 (fr) | 1984-11-07 | 1987-03-06 | Sanofi Sa | Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale |
JPS61130301A (ja) | 1984-11-30 | 1986-06-18 | Tokyo Univ | 抗凝血活性を有する硫酸化キシロフラナン及びその製造法 |
JPS61130302A (ja) | 1984-11-30 | 1986-06-18 | Tokyo Univ | 抗凝血活性を有する硫酸化リボフラナン及びその製造法 |
JPS624362A (ja) | 1985-07-01 | 1987-01-10 | Victor Co Of Japan Ltd | 固体撮像素子 |
US5672334A (en) | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
FR2645745B1 (fr) * | 1989-04-12 | 1991-09-27 | Anben Ste Civile | Compositions therapeutiques pour le traitement ou la prevention du ronflement |
DE3917982A1 (de) | 1989-06-02 | 1990-12-06 | Behringwerke Ag | Verwendung von xylanpolyhydrogensulfaten zur therapie von zellproliferations-bedingten erkrankungen |
FR2648463B1 (fr) | 1989-06-14 | 1993-01-22 | Inst Fs Rech Expl Mer | Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention |
AU647484B2 (en) | 1990-04-26 | 1994-03-24 | Cytrx Corporation | Composition and method for topical treatment of damaged or diseased tissue |
US20010005720A1 (en) | 1995-06-07 | 2001-06-28 | U.S.A. As Represented By The Secretary Department Of Health And Human Services | Method of treating chronic progressive vascular scarring diseases |
DE19632840A1 (de) * | 1996-08-14 | 1998-02-19 | Landsberger Albert | Vitamin A-haltige Zusammensetzung |
JPH10195107A (ja) | 1997-01-10 | 1998-07-28 | Shiseido Co Ltd | オリゴ硫酸化ヒアルロン酸 |
JP4336905B2 (ja) * | 1997-12-19 | 2009-09-30 | マルホ株式会社 | 硫酸化多糖類含有皮膚保湿乳剤性ローション剤 |
US6593310B1 (en) | 2000-11-21 | 2003-07-15 | Arthropharm Pty. Ltd. | Treatment of osteoporosis |
DE10141106A1 (de) | 2001-08-22 | 2003-03-13 | Aventis Pharma Gmbh | Verwendung von Heparinoid-Derivaten zur Behandlung und Diagnose von mit Heparinoiden behandelbaren Erkrankungen |
JP4073661B2 (ja) | 2001-12-20 | 2008-04-09 | 王子製紙株式会社 | 酸性キシロオリゴ糖組成物の製造方法 |
JP3772749B2 (ja) | 2002-01-25 | 2006-05-10 | 王子製紙株式会社 | メラニン生成抑制剤 |
JP2003221339A (ja) | 2002-01-29 | 2003-08-05 | Oji Paper Co Ltd | 抗炎症剤 |
ITMI20031618A1 (it) | 2003-08-06 | 2005-02-07 | Inalco Spa | Derivati polisaccaridici dotati di alta attivita' |
PT1748781E (pt) | 2004-05-27 | 2013-01-22 | Baxter Int | Processos para o tratamento de distúrbios de hemorragias utilizando polissacarídeos sulfatados |
AU2005271349B2 (en) | 2004-08-05 | 2011-10-27 | Ivax Drug Research Institute Ltd | Polysulfated glycosides and salts thereof |
US20060194759A1 (en) | 2005-02-25 | 2006-08-31 | Eidelson Stewart G | Topical compositions and methods for treating pain and inflammation |
CA2616230A1 (en) | 2005-07-22 | 2007-02-01 | Trf Pharma, Inc. | Method for treating sickle cell disease and sickle cell disease sequelae |
NZ571537A (en) | 2006-04-03 | 2012-06-29 | Nutramax Lab Inc | Stabilized pentosan polysulfate (PPS) formulations and methods of analayzing them |
GB0610350D0 (en) | 2006-05-25 | 2006-07-05 | Univ Liverpool | prevention and/or treatment of neuodegenerative disorders |
JPWO2008066193A1 (ja) | 2006-11-27 | 2010-03-11 | チッソ株式会社 | 化粧料組成物 |
US20100105889A1 (en) | 2007-03-06 | 2010-04-29 | Pandurang Balwant Deshpande | Process for the preparation of pentosan polysulfate or salts thereof |
FI121811B (fi) | 2007-06-01 | 2011-04-29 | Upm Kymmene Corp | Uudet dispersiot ja menetelmä niiden valmistamiseksi |
HUP0900072A2 (hu) * | 2009-02-06 | 2010-09-28 | Egis Gyogyszergyar Nyilvanosan | Transzdermális gyógyszerkészítmények |
WO2009087581A1 (en) | 2008-01-04 | 2009-07-16 | Alembic Limited | An improved process for the preparation of pentosan polysulfate or salts thereof |
JP2009196915A (ja) | 2008-02-20 | 2009-09-03 | Ezaki Glico Co Ltd | 化粧品用組成物 |
AU2008100725B4 (en) * | 2008-07-04 | 2008-10-02 | Parnell Technologies Pty Ltd | A sulfated polysaccharide compound for clinical use |
FR2935386B1 (fr) | 2008-08-26 | 2010-09-10 | Sanofi Aventis | Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine |
CN102300870B (zh) | 2009-02-02 | 2014-12-03 | 大塚化学株式会社 | 低分子量多硫酸化透明质酸衍生物和含有它的医药 |
CN102061323B (zh) | 2010-11-10 | 2013-09-25 | 山东龙力生物科技股份有限公司 | 一种植物木质纤维素的综合利用工艺 |
WO2012101544A1 (en) | 2011-01-29 | 2012-08-02 | Alembic Pharmaceuticals Limited | An improved process for the preparation of pentosan polysulfate or salts thereof |
WO2012114349A1 (en) | 2011-02-23 | 2012-08-30 | Cadila Healthcare Limited | An improved process for the preparation of pentosan polysulfate sodium |
CN102766225B (zh) | 2011-05-06 | 2015-08-05 | 上海医药工业研究院 | 一种戊聚糖聚硫酸钠的制备方法以及一种寡聚木糖 |
WO2013186857A1 (ja) | 2012-06-12 | 2013-12-19 | 株式会社リボミック | Fgf2に対するアプタマー及びその使用 |
ITMI20130112A1 (it) | 2013-01-24 | 2014-07-25 | Chemi Spa | Metodo di qualificazione di preparazioni di pentosan polifosfato, sue materie prime e processi di produzione |
JO3529B1 (ar) | 2013-02-08 | 2020-07-05 | Amgen Res Munich Gmbh | مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد |
JP6132302B2 (ja) | 2013-05-28 | 2017-05-24 | リーディアント・バイオサイエンシーズ・ソシエタ・アノニマLeadiant Biosciences S.A. | 抗血管新生活性を有し、抗凝血効果を有さない、ヘパラナーゼ阻害剤としての部分的に脱硫酸化されたグリコサミノグリカンの誘導体 |
CN103320548A (zh) | 2013-06-24 | 2013-09-25 | 稼禾生物股份有限公司 | 一种利用农作物秸秆制备低聚木糖和纤维素的方法 |
JP6403317B2 (ja) | 2013-07-19 | 2018-10-10 | 学校法人慶應義塾 | 抗腫瘍剤 |
SI3298047T1 (sl) | 2015-05-20 | 2022-04-29 | Chemi Spa | Postopek za pripravo polisaharidov |
US20180318336A1 (en) | 2015-05-27 | 2018-11-08 | Vanguard Therapeutics, Inc. | Pentosan polysulfate sodium for the treatment of sickle cell disease |
CN106832020A (zh) | 2015-12-04 | 2017-06-13 | 长春工业大学 | 一种玉米秸秆戊聚糖硫酸酯的制备工艺 |
CN105907896B (zh) | 2016-05-16 | 2019-11-12 | 中国科学院广州能源研究所 | 一种利用木质纤维原料联产高浓度木糖和低聚木糖的方法 |
SG11202001824RA (en) | 2016-08-31 | 2020-04-29 | Oji Holdings Corp | Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide |
JP6225321B1 (ja) | 2016-08-31 | 2017-11-08 | 王子ホールディングス株式会社 | ポリ硫酸ペントサンの製造方法 |
JP6281659B1 (ja) | 2017-02-28 | 2018-02-21 | 王子ホールディングス株式会社 | ポリ硫酸ペントサン、医薬組成物及び抗凝固剤 |
-
2018
- 2018-05-30 BR BR112019025030-1A patent/BR112019025030A2/pt unknown
- 2018-05-30 CN CN201880035306.7A patent/CN110678189A/zh active Pending
- 2018-05-30 EP EP18809395.9A patent/EP3632451A4/en active Pending
- 2018-05-30 SG SG10201913607WA patent/SG10201913607WA/en unknown
- 2018-05-30 SG SG11201911318SA patent/SG11201911318SA/en unknown
- 2018-05-30 JP JP2018553269A patent/JP6555431B2/ja active Active
- 2018-05-30 CA CA3065747A patent/CA3065747A1/en active Pending
- 2018-05-30 US US16/617,783 patent/US11278485B2/en active Active
- 2018-05-30 KR KR1020197037994A patent/KR20200011467A/ko active Application Filing
- 2018-05-30 KR KR1020247005048A patent/KR20240023711A/ko active Search and Examination
- 2018-05-30 AU AU2018276567A patent/AU2018276567B2/en active Active
- 2018-05-30 MX MX2019014445A patent/MX2019014445A/es unknown
- 2018-05-30 WO PCT/JP2018/020644 patent/WO2018221547A1/ja active Application Filing
-
2019
- 2019-11-26 PH PH12019502676A patent/PH12019502676A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20240023711A (ko) | 2024-02-22 |
AU2018276567A1 (en) | 2019-12-19 |
WO2018221547A1 (ja) | 2018-12-06 |
EP3632451A1 (en) | 2020-04-08 |
SG10201913607WA (en) | 2020-03-30 |
CN110678189A (zh) | 2020-01-10 |
BR112019025030A2 (pt) | 2020-06-16 |
CA3065747A1 (en) | 2018-12-06 |
JPWO2018221547A1 (ja) | 2019-06-27 |
US20200146963A1 (en) | 2020-05-14 |
KR20200011467A (ko) | 2020-02-03 |
SG11201911318SA (en) | 2020-01-30 |
AU2018276567B2 (en) | 2021-09-16 |
JP6555431B2 (ja) | 2019-08-07 |
PH12019502676A1 (en) | 2020-10-19 |
EP3632451A4 (en) | 2021-03-10 |
US11278485B2 (en) | 2022-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019502676A1 (en) | Moisturizing topical preparation | |
NZ742208A (en) | Topical pharmaceutical formulations for treating inflammatory-related conditions | |
GEP20237506B (en) | Pcsk9 antagonist compounds | |
CR20200274A (es) | Oxadiazoles fungicidas | |
PH12019500579A1 (en) | Pharmaceutical composition | |
MX2016016593A (es) | Nuevos derivados de aminoalquibenzotiazepina y usos de los mismos. | |
WO2015070224A3 (en) | Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | |
PH12019502646A1 (en) | Pyrazole magl inhibitors | |
PH12018502109A1 (en) | Medicine obtained by combining fxr agonist and arb | |
MX2019003099A (es) | Composicion farmaceutica. | |
MX2019009606A (es) | Bis-compuestos para dispositivos opticamente activos. | |
SG11201907938RA (en) | Pentosan Polysulfate, Pharmaceutical Composition, And Anticoagulant | |
PH12020550125A1 (en) | Crystalline forms of 3-substituted 1,2,4-oxadiazole | |
MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
MX2020005483A (es) | Antagonistas de ildr2 y combinaciones de los mismos. | |
MX2020012989A (es) | Agente terapeutico para la fibrosis. | |
MX2019003097A (es) | Composicion farmaceutica. | |
MX2020011756A (es) | Compuesto farmaceutico, sales del mismo, formulaciones del mismo y metodos para hacer y usar el mismo. | |
MX2019010330A (es) | Formulaciones con mejora de la estabilidad. | |
MX2021010022A (es) | Composicion farmaceutica. | |
MX2019008338A (es) | Composicion farmaceutica que contiene sulglicotido o una sal farmaceuticamente aceptable del mismo para la prevencion o tratamiento del ojo seco. | |
PH12017502148A1 (en) | Pharmaceutical compositions and use thereof | |
PH12019502145A1 (en) | Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient | |
MY182634A (en) | Pharmaceutical containing sodium-dependent phosphate transporter inhibitor | |
EA201791483A1 (ru) | Фармацевтическая композиция для лечения микоза |